Jamie B. Oughton - Publications

INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol.

Journal: BJU international

Published: July 28, 2026

Project Optimus for Radiation Therapy-Drug Combinations: Moving Beyond the Maximum Tolerated Dose.

Journal: International journal of radiation oncology, biology, physics

Published: November 13, 2025

Radiating Excellence: A Decade of Pioneering Radiotherapy Trials and Collaborative Leadership at Leeds Cancer Research UK Clinical Trials Unit.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: June 10, 2025

Selective Effects of Acutely Administered N-Acetyl-Cysteine in Rodent Models of Nicotine-Conditioned Behaviours.

Journal: Addiction biology

Published: September 29, 2024

Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.

Journal: Health technology assessment (Winchester, England)

Published: September 09, 2024

A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: May 22, 2023

NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma.

Journal: EClinicalMedicine

Published: March 27, 2023

Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations-CONCORDE.

Journal: JCO precision oncology

Published: November 29, 2022

Obinutuzumab as consolidation after chemo-immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial.

Journal: British journal of haematology

Published: April 30, 2022

Correction to: Clinical trial recruiters' experiences working with trial eligibility criteria: results of an exploratory, cross-sectional, online survey in the UK.

Journal: Trials

Published: November 30, 2021

Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 18, 2021

Clinical trial recruiters' experiences working with trial eligibility criteria: results of an exploratory, cross-sectional, online survey in the UK.

Journal: Trials

Published: August 10, 2021